Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
The company to receive upfront and milestone payments, in addition to royalties
The company to receive upfront and milestone payments, in addition to royalties
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
Subscribe To Our Newsletter & Stay Updated